A killer disease might be nearing the end of its deadly run “This drug seems likely to be approved for sleeping sickness, and is an excellent example of drug discovery scientists ‘rescuing’ a compound that was otherwise in the dustbin of a large drug company,” Michael Pollastri, an associate professor at Northeastern University, told HuffPost.